OTC DISCLOSURE & NEWS SERVICE

Emerging Markets Report: The Tipping Point

ORLANDO, Fla., Oct. 07, 2020 (GLOBE NEWSWIRE) -- As regular readers of the Emerging Markets Report know we’re big fans of two things at the small cap level:
Transparency and Revenue.
And while we argue in-house about which matters more, the reality is no real deal can exist in perpetuity without both being in place. And that’s why we’re now most pleased with some recent developments by Isiah Thomas’s Colombian cannabis producer, One World Pharma Inc. (OTCQB: OWPC).
A short while ago, Thomas and team held a zoom Investor Presentation where they covered a myriad of items and took questions from investors. We highly encourage investors to take an opportunity to hear this first-person update on some really important developments for OWP.
It’s clear they are at a tipping point.
Here’s a link:
https://tinyurl.com/y3kalz9n

We appreciate Thomas’s transparency and proactivity. It’s more than clear that the legendary athlete is bringing a stellar business background to this cannabis play, most notably his success with Cheurlin Champagnes where a deep relationship with the soil and sun, the people and the plant are also required. Thomas’s hoops background aside, he appears to be very well prepared to lead OWP into what they are calling their ‘first revenue phase.’
It’s not going unnoticed. Check out a recent Benzinga feature about Isiah’s path to One World Pharma.
But it’s the ‘entering its first revenue phase’ statement that is what we’re really focused on with OWP. It could truly be transformative.
There are myriad cannabis plays in public markets. Very few are established in Colombia where Mr. Thomas often extols the “equatorial advantage” in the favorable climate for growing hemp and cannabis at scale.
Entering a revenue phase also means that the Company has climbed the logistical mountain of licensing, infrastructure, labor, and seed characterization. A gargantuan task no less.
As Isiah explains in the presentation, now comes an opportunity to harvest and sell, to solicit very large customers and grow to spec via its compelling Futures program and to at-last reap the harvest of revenue… from the harvest.
So we will continue to follow One World Pharma armed with more clarity about the opportunity, and as the Company at last pursues ever-important revenue from long anticipated harvests.

For more information on One World Pharma please visit:
www.OneWorldPharma.com
About One World Pharma

Formed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp and cannabis derived ingredients for use in the manufacturing of Medical, Pharmaceutical, Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia.

About The Emerging Markets Report:

The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.
For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.

Businessman Thomas

Joining One World Pharma as CEO and Vice-Chairman is far from Thomas’ first approach to business. In fact, his experience dates back to 1992 when while still leading the Detroit Pistons, Thomas purchased a distressed printing company out of bankruptcy which he subsequently sold. Thomas became the first NBA player to be featured on the cover of Forbes after his investment and turnaround.


Indiana Pacers coach Isiah Thomas gives instructions to his team against the Toronto Raptors in ... [+] ASSOCIATED PRESS

In 1994, the NBA entrusted him to essentially start the globalization of the basketball business in Canada with the Toronto Raptors franchise. That, Thomas says, was his first international business experience, and it was game changing.
“For someone who had just left the playing floor, for the NBA to really give you that major responsibility of going to Canada and introducing their first franchise outside of the United States... it was a huge responsibility, but it was also a huge compliment.”
Today, Thomas is especially proud of being Co-Founder of the Raptors. Twenty-five years later, the Toronto Raptors became the first international franchise to be crowned NBA Champions. “It warms my heart to know that the proper foundation was laid by the work that we did there early on,” said Thomas.

From Vines To Grass

Fast-forward to 2020, Thomas is now the sole owner of Cheurlin Champagnes, one of the most renowned family producers in the industry. They have been making Champagne since 1788 and Thomas was named ‘Champagne Producer of the Year’ by the New York International Wine Competition in 2018 and 2019, a feat Thomas values as much as his back-to-back NBA championships in 1989 and 1990.
Since purchasing Cheurlin in 2015, Thomas states that he has learned a lot about the fine art of Champagne making. What interested him the most about the process was the plant; understanding the growers, the soil, the sun, and the importance of the unique location… just about everything needed to grow the perfect grape.
But it’s not only extraordinary grapes that need ideal conditions to flourish.
Once introduced to One World Pharma, Thomas recognized that there are strong similarities to Champagne making in France and cultivating cannabis in Colombia. Both are unique geographical areas that are known worldwide for the quality of their plants.
As with Champagne only being allowed to be produced using specific grapes from the Champagne region of France due to the perfect combination of vines, soil, and sun, One World Pharma will produce elite plants from the perfect combination of its patented seeds, soil, and sun, he concludes.

https://www.forbes.com/sites/javierhasse/2020/07/07/isiah-thomas-cannabis/#56ad1eab5a2f

One World Pharma, Inc. (OWP)

U.S. News & World Report Article Identifies OWP as One of 7 Marijuana Stocks to Grow in 2020

U.S. News & World Report Article Identifies OWP as One of 7 Marijuana Stocks to Grow in 2020

LAS VEGAS, NV -- December 18, 2019 -- InvestorsHub NewsWire -- One World Pharma Inc. (OTCQB:OWPC),“OWP,” a fully licensed pure-play cannabis and hemp ingredient producer in Colombia was identified by an article in U.S. News & World Report as one of ‘7 Marijuana Stocks to Grow in 2020.” The story was the featured report on U.S. News and World Report’s popular “Money” section.

U.S. News & World Report is an American media company that publishes news, opinion, consumer advice, rankings, and analysis since 1933.

An excerpt from the article:
“One World Pharma, a Las Vegas-based licensed cannabis and hemp producer which cultivates and grows them in Popayan, Colombia, is an opportunity that investors should keep an eye out for, Michael Berger says. The company recently received a quota for 2020 production of THC, a main psychoactive compound in marijuana, in Colombia and is among the first companies to be issued an amount. “The Latin American market represents an attractive opportunity due to the economics associated with the production of cannabis,” he says. “Following the issuance of government licenses, the company is positioned to record strong growth in 2020.”

“We are pleased to be recognized in an article like this in a publication that people often look to for insight as to business and the markets,” stated Brian Moore, President, One World Pharma. “Our team has worked very hard to execute the One World mission, to assemble the necessary licenses, technology and relationships to pursue the Colombian opportunity.”

“We too are very excited about what 2020 may hold for One World Pharma,” added Moore.

Client Updates Delivered
Straight To Your Inbox

Email: 
   
Confirm Email
   

Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Current Report on 8-K/A filed with the Securities and Exchange Commission on July 12, 2019, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

One World Pharma Investor Relations & Financial Media Integrity Media
team@integritymedia.com
Toll Free: (888) 216-3595
www.IntegrityMedia.com

Recent News:

https://finance.yahoo.com/news/hemp-inc-signs-letter-intent-140010368.html  

DESCRIPTION

One World Pharma, Inc. (OWP), through its Colombian subsidiary, is a fully licensed global supplier of hemp and cannabis derived ingredients for use in manufacturing of Medical, Consumer Packaged Goods (CPGs) and Over the Counter (OTC) products. Currently, we own approximately 30 acres and have covered greenhouses built specifically to cultivate high-grade cannabis and hemp. We have entered into agreements with local farming co-operatives that include small and indigenous farmers, under which they will cultivate cannabis on up to approximately 110 acres of land using our seeds and propagation techniques, and sell their harvested products to us on an exclusive basis. We intend to offer our customers specific acreage that is allocated to a specific customer and with specified genetics. This will deliver consistent CBD, THC and other raw material ingredients at predetermined, consistent pricing.

 

Isiah Thomas, International Entrepreneur & Philanthropist, Becomes New CEO of Hemp Based Cannabis Company, One World Pharma

One World Pharma Adds New Leadership as Company Enters Revenue Phase
LAS VEGAS, June 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- One World Pharma Inc. (OTC: OWPC), “OWP,” a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce that effective immediately, NBA legend, international entrepreneur and philanthropist Isiah Thomas has been appointed as its CEO and Vice-Chairman of the Board of Directors. Mr. Thomas will replace founder and CEO Craig Ellins who is retiring.
Isiah Thomas, while forever known for his Hall of Fame career as a 12-time NBA All Star, two-time NBA champion, and inclusion as one of the 50 Greatest Players in NBA History, is an accomplished and highly regarded international business executive and investor with a portfolio of companies he has developed via Isiah International Inc. Mr. Thomas has previously served on the Chicago Stock Exchange’s Board of Governors, was a co-founder of the NBA’s Toronto Raptors, Popcorn Indiana, and is a member of the Board of Get-in Chicago, an organization focused on preventing gang violence in Chicago, since 2013.
His business interests include sports and entertainment, real estate, waste management, his cannabis and CBD products company, VESL Oils, and more. Notably, Mr. Thomas has developed a highly successful champagne business with Cheurlin Champagnes, where he has cultivated an excellent relationship with both the grower, employees and the French government. Mr. Thomas now uniquely owns genetics for the grapes produced for the champagne and has perfected an international import/export system for international distribution of the product.
Mr. Thomas inherits the reins of an ascendant international hemp and cannabis company which under Mr. Ellins’ leadership has seen significant development and progress, including the establishment of highly scalable farm and production facilities in Colombia, a portfolio of fully registered elite and government approved genetic strains, and a state sanctioned THC quota.
The Board of Directors is grateful to Mr. Ellins and thanks him for his innovation, dedication, and determination.
“We are elated to welcome Isiah Thomas to the One World Pharma leadership team and to have him continue and expand upon the successes of Craig Ellins,” stated Dr. Kenneth Perego, Executive Chairman of One World Pharma. “Mr. Thomas is the ideal person to lead us in this new phase as we commence commercial sales and revenues, lending to our cause his international business experience, myriad relationships, and commitment to winning.”
“It is truly an honor to work with Mr. Thomas on the One World Pharma opportunity and to leverage his experience in such similar verticals to the benefit of the Company, its shareholders and our indigenous partners in Colombia,” added Brian Moore, President, One World Pharma.
“I am honored to join One World Pharma and its excellent team. It is a company that is leading the way in innovation in the hemp and cannabis industry,” said Isiah Thomas, CEO and Vice-Chairman. “The company’s deep commitment to excellence in their products and for its customers positions us well to continue to grow as an international leader in the industry. Its recognition for its humanitarian efforts validates its mission as a socially conscious company in a true partnership with the indigenous people.”

One World Pharma Investor Relations & Financial Media
Integrity Media
team@integritymedia.com
Toll Free: (888) 216-3595
www.IntegrityMedia.com

Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Isiah Thomas, CEO of One World Pharma, Announces First Colombian Seed SalesPress Release | 06/25/2020  
https://www.otcmarkets.com/stock/OWPC/news/Isiah-Thomas-CEO-of-One-World-Pharma-Announces-First-Colombian-Seed-Sales?id=265913  
•June 4, 2020

https://ir.oneworldpharma.com/

For more information on One World Pharma please visit:

www.OneWorldPharma.com

About The Emerging Markets Report:

The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stock brokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.

http://emergingmarketsllc.com/disclaimer.php

Recent News:

https://finance.yahoo.com/news/isiah-thomas-ceo-one-world-130010609.html
https://finance.yahoo.com/news/isiah-thomas-international-entrepreneur-philanthropist-130010689.html
https://www.otcmarkets.com/stock/OWPC/news/US-News--World-Report-Article-Identifies-OWP-as-One-of-7-Marijuana-Stocks-to-Grow-in-2020?id=249638

DISCLAIMER:

EMC has been paid 165,000 dollars and 425,000 restricted shares by One World Pharma. EMC has a contract to receive 40,000 dollars over the next six months.
KP Investment partners invested 50,000 dollars in One World Pharma. EMC acquired a unit that translates into shares at .20 and a warrant. CEO of Emerging Markets James Painter has a 50% ownership stake in KP Investment partners
Additionally, Integrity Media holds 780,000 shares and receives $4,000 a month for a period of twenty-four months for investor relations services on behalf of One World Pharma.
https://www.emergingmarketsllc.com/disclaimer/

Must Read OTC Markets/SEC policy on stock promotion and investor protection

https://www.otcmarkets.com/learn/policy-on-stock-promotion
https://www.otcmarkets.com/learn/investor-protection
https://www.sec.gov/news/press-relesase/2017-79
https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html

Emerging Markets Consulting, LLC
Florida Office
15701 State Road 50, Suite #205
Clermont, FL 34711
E-mail: jamespainter@emergingmarketsllc.com
Web:www.emergingmarketsllc.com